Tahir Khan, DPM
Podiatrist · Milwaukee, WINPI 1073880936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $256 and has fallen 53.5% since, to $119 in 2025. That places this record below the midpoint for podiatrist clinicians in WI, where the typical reported total is $1,012.
Across 30 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$136
- Bayer$117
- Merck$83
- Nestle Healthcare Nutrition Inc.$78
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$77
- Ardelyx, Inc.$66
- plus $168 from 9 others
What the payments were for
- Food & beverage$725100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $136 |
| Bayer | 6 | $117 |
| Merck | 1 | $83 |
| Nestle Healthcare Nutrition Inc. | 4 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Ardelyx, Inc. | 3 | $66 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Neurelis, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca | 1 | $12 |
| Biofire Diagnostics, LLC | 1 | $12 |
| Next Science LLC | 1 | $9 |
How this compares
$725 in reported general payments places this provider in the 45th percentile of 140 podiatrist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 611 | $15,855 |
| Nystatin | 175 | $1,785 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 99 | $1,749 |
| Mupirocin | 194 | $1,455 |
| Ciclopirox | 42 | $1,384 |
| Lidocaine | 29 | $1,127 |
| Clotrimazole | 33 | $967 |
| Gabapentin | 100 | $587 |
| Cephalexin | 47 | $339 |
| Clindamycin Hcl | 29 | $205 |
| Meloxicam | 47 | $176 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $168 |
| Oxycodone Hcl | 14 | $67 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $38 |
| Azithromycin | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Milwaukee
- Nicholas WilliamsMilwaukee$7K
- Adam FinzenMilwaukee$6K
- Valeria HairstonMilwaukee$6K
- Jason BoudreauMilwaukee$5K
- Vanessa ScoarsteMilwaukee$5K
- Sam WierMilwaukee$4K
- Warren McIverMilwaukee$2K
- Aaron SchwankeMilwaukee$2K
- Bradley Abichtla Crosse$308K
- Scott Carringtonla Crosse$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.